Posted in | News | Business

SciAps Receives Additional Investment From Gefinor Ventures

SciAps, Inc. (SciAps or the Company), a Boston-based instrumentation company specializing in handheld and portable analytical instruments, recently announced that it has received a $2.5 million investment led by new investor Gefinor Ventures, with follow-on participation from existing investors Rand Capital, and Coastal Ventures.

Founded in 2012, SciAps is an instrumentation company specializing in portable, durable, field- tested instruments that are used to identify compounds, minerals, and elements, both on-site and in real-time. The Company’s products use laser technology to quickly identify compounds, minerals, and elements of interest to the user. SciAps’ analyzers are used for a wide variety of end-use applications, ranging from alloy analysis, mining and exploration, pharmaceuticals and nutraceuticals, plastics and polymers, law enforcement, and hazmat first responders.

“Our mission is to provide durable, field-tested, portable instruments to identify any compound, any mineral, any element; anyplace on the planet,” said Don Sackett, President of SciAps. “This latest round of investment completes the funding for some great new portable products we’ll be demonstrating early next year. It’s really an exciting time to be introducing new technology to the portable analytical instruments markets.”

“We are excited to welcome SciAps to Gefinor Ventures’ family of leading technology companies,” said Christopher Davis, Principal at Gefinor Ventures, who has joined the SciAps Board of Directors. “SciAps has the right blend of unique technology, market knowledge, and global reach to achieve rapid growth.” Daniel Penberthy, Executive Vice President with Rand Capital, has also joined the SciAps Board of Directors.

Founded in 2012, SciAps is headquartered in Woburn, MA. Manufacturing, service and customer support are operated from the Company’s fully ISO-certified facility in Laramie, WY. SciAps maintains worldwide sales and service alliances, with installation and training available in more than 100 countries.

For more information, please visit: www.sciaps.com.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    SciAps, Inc.. (2019, February 08). SciAps Receives Additional Investment From Gefinor Ventures. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=39101.

  • MLA

    SciAps, Inc.. "SciAps Receives Additional Investment From Gefinor Ventures". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=39101>.

  • Chicago

    SciAps, Inc.. "SciAps Receives Additional Investment From Gefinor Ventures". AZoM. https://www.azom.com/news.aspx?newsID=39101. (accessed November 21, 2024).

  • Harvard

    SciAps, Inc.. 2019. SciAps Receives Additional Investment From Gefinor Ventures. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=39101.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.